Concise Advice on Inpatient Diabetes during COVID-19 - Safe and supported discharge to reduce readmissions and improve patient flow
This week at the ABCD Conference 2020, ABCD is pleased to announce the launch of the ABCD worldwide audit of testosterone deficiency in men with type 2 diabetes. The condition has a high prevalence - 40% of men with type 2 diabetes have symptomatic testosterone deficiency. Testosterone deficiency is associated with: an adverse effect on cardiovascular risk factors, osteoporosis, reduced muscular strength (including frailty), anaemia and reduced psychological well-being. Testosterone deficiency is also associated w
ABCD executive team will be delighted if you can complete this short survey which is designed to gain some early insight into the state of integrated care, both clinical as well as supported by IT in UK. In addition, we are keen to find out your considered opinion about the annual review process for diabetes, which remains a fundamental aspect of ongoing diabetes care.
We believe that, the information gained form this survey, will help inform the ABCD work on recovery and future of diabetes services, post COVID in UK.
Diabetes UK have announced the new cohort of clinical champions to help transform services and improve local care. You may recognise some of your colleagues in the list, please do wish them well and provide local support.
Working together to enhance access to technology for people living with diabetes.
Welcome to the DTN-UK Virtual Showroom. Here you will find links to our Corporate Supporter's technologies designed to improve the lives of people living with diabetes.
Presented at the ACBD Regional Meeting, Yorkshire 2020 by Dr Bob Ryder
Presented at the ACBD Regional Meeting, Yorkshire 2020 by Dr Chris Walton, Hull & Keren Miller, Oviva
Presented at the ACBD Regional Meeting, Yorkshire 2020 by Professor Ramzi Ajjan
